Company / Depreciation & Amortization
CANNAPHARMARX, INC. Depreciation & Amortization History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
-
FY2024
5-year range
$0 / $294.9K
FY2020-FY2024
Trend
-100.0%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2,708 to $0 over the past 3 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, depreciation & amortization decreased 100.0% year-over-year.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -18.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $0 | -100.0% |
| FY2022 | $294.9K | +10791.2% |
| FY2021 | $2.7K | -97.9% |
| FY2020 | $128.5K | -0.4% |
| FY2019 | $129.0K | - |
| FY2018 | $0 | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026